MedPath

GRIN THERAPEUTICS, INC.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private
Employees
-
Market Cap
-
Website

Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.

Phase 1
Not yet recruiting
Conditions
Tuberous Sclerosis Complex (TSC)
Focal Cortical Dysplasia
Other Neurological Disorders
Interventions
Drug: Radiprodil + co-administered drugs
First Posted Date
2025-05-16
Last Posted Date
2025-05-16
Lead Sponsor
GRIN Therapeutics, Inc.
Target Recruit Count
18
Registration Number
NCT06975605
Locations
πŸ‡¦πŸ‡Ί

Nucleus Network Melbourne, Melbourne, Victoria, Australia

Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults

Phase 1
Recruiting
Conditions
Tuberous Sclerosis Complex (TSC)
Focal Cortical Dysplasia
Other Neurological Disorders
Interventions
Drug: Radiprodil with Carbamazepine
Drug: Radiprodil with Itraconazole
First Posted Date
2025-05-11
Last Posted Date
2025-05-22
Lead Sponsor
GRIN Therapeutics, Inc.
Target Recruit Count
36
Registration Number
NCT06965881
Locations
πŸ‡¦πŸ‡Ί

Q-Pharm Pty Ltd, Brisbane, Queensland, Australia

πŸ‡¦πŸ‡Ί

Nucleus Network Pty Ltd, Melbourne, Victoria, Australia

Astroscape: a Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients with TSC or FCD Type II

Phase 1
Recruiting
Conditions
Focal Cortical Dysplasia
Tuberous Sclerosis Complex
Interventions
First Posted Date
2024-04-30
Last Posted Date
2024-12-09
Lead Sponsor
GRIN Therapeutics, Inc.
Target Recruit Count
30
Registration Number
NCT06392009
Locations
πŸ‡¦πŸ‡Ί

Queensland Children Hospital, South Brisbane, Australia

πŸ‡§πŸ‡ͺ

Universitair Ziekenhuis Antwerpen (UZA), Antwerp, Belgium

πŸ‡§πŸ‡ͺ

University Hospitals Leuven, Pediatric Neurology, Leuven, Belgium

and more 17 locations

Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder

Phase 1
Active, not recruiting
Conditions
GRIN-related Disorders
Interventions
First Posted Date
2023-04-19
Last Posted Date
2024-11-15
Lead Sponsor
GRIN Therapeutics, Inc.
Target Recruit Count
24
Registration Number
NCT05818943
Locations
πŸ‡³πŸ‡±

UMC Utrecht - Wilhelmina Kinderziekenhuis, Polikliniek Kinderneurologie, Utrecht, Netherlands

πŸ‡ͺπŸ‡Έ

Universitat de Barcelona - Hospital Sant Joan de Deu Barcelona (HSJDB), Barcelona, Spain

πŸ‡ΊπŸ‡Έ

Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland, United States

and more 12 locations
Β© Copyright 2025. All Rights Reserved by MedPath